Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1981 | 12-1980 | 12-1979 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 422,800 | 298,200 | 303,000 |
| Marketable Securities | 144,100 | 192,400 | 175,800 |
| Receivables | 750,000 | 718,300 | 653,800 |
| Inventories | 848,200 | 891,500 | 741,900 |
| Other current assets | 95,000 | 73,800 | 53,200 |
| TOTAL | $2,260,100 | $2,174,200 | $1,927,700 |
| Non-Current Assets | |||
| Investments And Advances | 186,300 | 179,700 | 197,300 |
| Other Non-Current Assets | 202,500 | 184,800 | 164,800 |
| TOTAL | $388,800 | $364,500 | $362,100 |
| Total Assets | $3,647,100 | $3,363,700 | $3,049,100 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 225,400 | 244,600 | 242,300 |
| Accrued Expenses | 112,700 | 96,300 | 72,200 |
| Other current liabilities | 194,500 | 161,600 | 152,000 |
| TOTAL | $1,123,800 | $1,096,800 | $954,600 |
| Non-Current Liabilities | |||
| Long Term Debt | 690,000 | 583,100 | 565,500 |
| Other Non-Current Liabilities | 76,000 | 75,600 | 68,500 |
| TOTAL | $825,700 | $703,000 | $680,600 |
| Total Liabilities | $1,912,100 | $1,765,600 | $1,605,700 |
| Shareholders' Equity | |||
| Common Shares | 7,500 | 7,400 | 8,200 |
| Retained earnings | 1,396,800 | 1,328,500 | 1,188,400 |
| Other shareholders' equity | 200 | 100 | 100 |
| TOTAL | $1,697,600 | $1,563,900 | $1,413,900 |
| Total Liabilities And Equity | $3,609,700 | $3,329,500 | $3,019,600 |